PMID: 12786614Jun 6, 2003Paper

Review article: test and treat or treat and test in reflux disease?

Alimentary Pharmacology & Therapeutics
N Vakil

Abstract

The role of diagnostic testing in reflux disease is in evolution. There is little question that patients with dysphagia, bleeding or other 'alarm' symptoms, should undergo early endoscopy. A substantial proportion of patients presenting with reflux symptoms have endoscopy negative reflux disease. pH testing is both inconvenient and lacks the sensitivity and specificity required for a 'gold standard'. Empirical trials of therapy using proton pump inhibitors have shown that a trial of treatment may be the most accurate way of diagnosing gastro-oesophageal reflux disease (GERD) and may the optimal strategy from a cost-effectiveness standpoint. On the other hand, the increasing rate of oesophageal adenocarcinoma has raised questions about the possible value of screening endoscopy to determine if Barrett's oesophagus is present. The role of endoscopic testing in the average patient is therefore shifting from a diagnostic modality to one that helps manage risk by identifying Barrett's oesophagus.

References

Aug 1, 1987·Scandinavian Journal of Gastroenterology·F JohnssonL Greiff
Jan 20, 1999·Alimentary Pharmacology & Therapeutics·C M BateM D Taylor
Mar 18, 1999·The New England Journal of Medicine·J LagergrenO Nyrén
Sep 24, 1999·The American Journal of Medicine·J J OfmanR Fass
Aug 17, 2000·JAMA : the Journal of the American Medical Association·J LagergrenO Nyrén
Aug 19, 2000·The American Journal of Gastroenterology·A SoniA Sonnenberg
Sep 5, 2001·The British Journal of Surgery·H M KocherJ P Ellul
Feb 1, 2003·Annals of Internal Medicine·John M InadomiNimish Vakil

❮ Previous
Next ❯

Related Concepts

Related Feeds

Barrett Esophagus

Barrett’s esophagus if a serious complication of gastroesophageal reflux disease during which the normal esophageal lining changes to tissue that resembles intestinal lining. Here is the latest research.